[1]
Sabirova, X. 2026. CRISPR-Cas13 RNA Editing for Tauopathy Treatment: Single-AAV Delivery from VIVARY Lab. Journal of Clinical and Biomedical Research. 1, 1 (Jan. 2026), 289–293.